Dyne Therapeutics(DYN.US) Officer Sells US$4.05 Million in Common Stock
$Dyne Therapeutics(DYN.US)$ Officer Scalzo Richard William sold 126.07K shares of common stock on Sep 6, 2024 at an average price of $32.15 for a total value of $4.05 million.Source: Announcement
Form 144 | Dyne Therapeutics(DYN.US) Officer Proposes to Sell 4.24 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 6, $Dyne Therapeutics(DYN.US)$ Officer Scalzo Richard William intends to sell 126.07K shares of its common stock on Aug 19, with a total market value of approximately $4.24
CEO, President & Director of Dyne Therapeutics John Cox Buys 640% More Shares
Form 144 | Dyne Therapeutics(DYN.US) Officer Proposes to Sell 5.61 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 5, $Dyne Therapeutics(DYN.US)$ Officer McNeill Jonathan intends to sell 166.77K shares of its common stock on Sep 5, with a total market value of approximately $5.61
H.C. Wainwright Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $55
H.C. Wainwright analyst Andrew Fein maintains $Dyne Therapeutics(DYN.US)$ with a buy rating, and maintains the target price at $55.According to TipRanks data, the analyst has a success rate of 46.2%
Dyne Therapeutics Insider Bought Shares Worth $1,057,216, According to a Recent SEC Filing